BMJ Best Practice
最后审核时间： 十月 2018
最近更新时间： 四月 2018

小结

定义

病史和查体

关键诊断因素

  • 存在的危险因素
  • previous superficial vein thrombophlebitis (SVT), deep vein thrombosis (DVT), or pulmonary embolism (PE)
  • 患处皮肤红斑/发红
  • 皮肤温度升高/发热
全部具体信息

其他诊断因素

  • 静脉曲张
  • 近期的静脉腔内器械操作（例如硬化治疗）
  • 近期的静脉置管和静脉内药物注射
  • 低热
全部具体信息

危险因素

  • 静脉曲张
  • 易栓疾病
  • 自体免疫性疾病（例如，白塞病和血栓闭塞性脉管炎）
  • 既往 SVT 病史
全部具体信息

诊断性检查

首要检查

  • 多普勒超声检查
全部具体信息

需要考虑的检查

  • 活检
  • 肺动脉 CT 血管成像
  • 通气灌注 (ventilation perfusion, VQ) 扫描
  • 选择性肺动脉造影
全部具体信息

治疗流程

推断

extension into the femoral vein or popliteal vein, <2 cm from the saphenofemoral junction, or concomitant DVT or PE

急性

SVT：长度≥5 cm 和/或在隐股静脉瓣连接处 3-5 cm 范围内

SVT：局部静脉扩张（曲张静脉炎）长度＜5 cm，不在隐股静脉瓣连接处 3-5 cm 范围内，没有 VTE 危险因素

SVT：局部静脉扩张（曲张静脉炎）长度＜ 5 cm，不在隐股静脉瓣连接处 3-5 cm 范围内，至少有一项 VTE 危险因素

疾病持续状态

复发性浅静脉血栓性静脉炎 (SVT) 伴随广泛的静脉曲张

贡献者

作者 查看所有

Vicky Tagalakis MD, FRCPC, MSC

Associate Professor

Department of Medicine

McGill University

Montreal

Canada

利益冲突披露
VT has received reimbursement for consultancy work for Pzifer Canada, Sanofi Canada, Bayer, Bristol Myer Squib, and Leo Pharma. She has received an investigator-initiated grant from Sanofi Canada.

Professor Vicky Tagalakis would like to gratefully acknowledge Frédérique St-Pierre, a medical student who worked with her to update this topic.

利益冲突披露
FSP declares that he has no competing interests.

同行评议专家 查看所有

Consultant

Division of Angiology and Hemostasis

University Hospital of Geneva

Geneva

Switzerland

利益冲突披露
FB declares that he has no competing interests.

Professor of Medicine

Section of Hematology

Director of Hematologic Malignancies

Temple University School of Medicine

Philadelphia

PA

利益冲突披露
MB declares that he has no competing interests.

The Mary Weinfeld Professor of Clinical Research in Hemophilia

Mount Sinai School of Medicine

New York

NY

利益冲突披露
LA declares that he has no competing interests.

使用此内容应接受我们的免责声明。